SCHEMBL81781

SCHEMBL81781

CCCC(=O)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899647 0.85
SCHEMBL3708578 0.83 KMT2A (0.50)
SCHEMBL27987764 0.81 KMT2A (0.54)
SCHEMBL11247459 0.81 KMT2A (0.54)
SCHEMBL28525468 0.81 KMT2A (0.54)
SCHEMBL5462822 0.81 KMT2A (0.54)
SCHEMBL609943 0.78
SCHEMBL3085878 0.77
SCHEMBL8007919 0.77 MCL1 (0.39)
SCHEMBL3992204 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113304747-B Catalyst for preparing 2-methylpyridine, preparation method and method for preparing 2-methylpyridine by using same 万华化学集团股份有限公司 2022-07-12 CN disclosed
US-20220119409-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2022-04-21 US disclosed
CN-114341128-A Bifunctional protein degradation targeting chimera compound and preparation method and medical application thereof 恩瑞生物医药科技(上海)有限公司 2022-04-12 CN disclosed
CN-113304747-A Catalyst for preparing 2-methylpyridine, preparation method and method for preparing 2-methylpyridine by using same 万华化学集团股份有限公司 2021-08-27 CN disclosed
CN-104903310-B Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain 阵列生物制药公司 2018-08-14 CN disclosed
CN-108329246-A Pyrrolidinyl urea and pyrrolidinyl thiourea compound as TRKA kinase inhibitors 阵列生物制药公司 2018-07-27 CN disclosed
CN-105130967-B Pyrrolidinyl urea and pyrrolidinyl thiourea compound as TRKA kinase inhibitors 阵列生物制药公司 2018-04-17 CN disclosed
US-20180009784-A1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2018-01-11 US disclosed
US-20170260143-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2017-09-14 US disclosed
US-9688640-B2 Methods of treating cancer with a pyrazole derivative ASTRAZENECA AB (SE) 2017-06-27 US disclosed
EP-0496630-B1 2-Cyano-1,3-dione herbicides RHONE POULENC AGRICULTURE (GB) 1995-06-07 EP disclosed
EP-0649303-A1 SUBSTITUTED ARGININES AND SUBSTITUTED HOMOARGININES AND USE THEREOF CORNELL RESEARCH FOUNDATION, INC. (US) 1995-04-26 EP disclosed
US-5281627-A Guanidine substituted arginines CORNELL RESEARCH FOUNDATION, INC. (US) 1994-01-25 US disclosed
WO-1993024126-A1 SUBSTITUTED ARGININES AND SUBSTITUTED HOMOARGININES AND USE THEREOF CORNELL RESEARCH FOUNDATION, INC. (US) 1993-12-09 WO disclosed
US-5260285-A Substituted imidazopyridazines as angiotensin II antagonists MERCK & CO., INC. (US) 1993-11-09 US disclosed
US-5250521-A Administering in treatment of eleuated blood pressure, conjestive heart failure and ocular hypertension MERCK & CO., INC. (US) 1993-10-05 US disclosed
EP-0496630-A1 2-Cyano-1,3-dione herbicides RHONE-POULENC AGRICULTURE LTD. (GB) 1992-07-29 EP disclosed
EP-0490587-A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin II antagonists MERCK & CO. INC. (US) 1992-06-17 EP disclosed
EP-0135252-A2 Process for preparing 3-substituted-3-aminonitrile ELI LILLY AND COMPANY (US) 1985-03-27 EP disclosed
EP-0129408-A2 (3-alkyl-5-isothiazolyl)ureas ELI LILLY AND COMPANY (US) 1984-12-27 EP disclosed